Chagas disease. What is known and what should be improved: a systemic review.
about
Chagas disease in the 21st century: a public health success or an emerging threat?Role of Small RNAs in Trypanosomatid InfectionsNovel amidines and analogues as promising agents against intracellular parasites: a systematic reviewPreventing the transmission of American trypanosomiasis and its spread into non-endemic countriesSoulamarin isolated from Calophyllum brasiliense (Clusiaceae) induces plasma membrane permeabilization of Trypanosoma cruzi and mytochondrial dysfunctionHepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethylnitrofurazone: a comparison with BenznidazoleChallenges and perspectives of Chagas disease: a review.Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatmentSelecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infectionsGenome-wide screening and identification of new Trypanosoma cruzi antigens with potential application for chronic Chagas disease diagnosis.Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.Epidemiology of and impact of insecticide spraying on Chagas disease in communities in the Bolivian Chaco.Autochthonous transmission of Chagas disease in Rio de Janeiro State, Brazil: a clinical and eco-epidemiological study.The use of a heterogeneously controlled mouse population reveals a significant correlation of acute phase parasitemia with mortality in Chagas disease.Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine modelChanges in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas DiseaseSIRT1-PGC1α-NFκB Pathway of Oxidative and Inflammatory Stress during Trypanosoma cruzi Infection: Benefits of SIRT1-Targeted Therapy in Improving Heart Function in Chagas Disease.Domestic Pig (Sus scrofa) as an Animal Model for Experimental Trypanosoma cruzi Infection.Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas DiseaseHost and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathyA scientometric evaluation of the Chagas disease implementation research programme of the PAHO and TDR.Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity.Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity.Chagas disease reactivation in a heart transplant patient infected by domestic Trypanosoma cruzi discrete typing unit I (TcIDOM)Lineage-specific serology confirms Brazilian Atlantic forest lion tamarins, Leontopithecus chrysomelas and Leontopithecus rosalia, as reservoir hosts of Trypanosoma cruzi II (TcII).Trypanocidal Activity of Long Chain Diamines and Aminoalcohols.Lack of Efficacy of Liposomal Amphotericin B Against Acute and Chronic Trypanosoma cruzi Infection in Mice.TGF-β receptor type II costameric localization in cardiomyocytes and host cell TGF-β response is disrupted by Trypanosoma cruzi infection.Trypanosoma cruzi DTU TcII presents higher blood parasitism than DTU TcI in an experimental model of mixed infection.Is autonomic function associated with left ventricular systolic function in Chagas heart disease patients undergoing treatment for heart failure?Current epidemiological profile of Chagasic megaesophagus in Central Brazil.Serological and molecular inquiry of Chagas disease in an Afro-descendant settlement in Mato Grosso do Sul State, Brazil.RADIOLOGICAL STUDY OF MEGACOLON IN TRYPANOSOMA CRUZI INFECTED RATS.Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole
P2860
Q24594371-CC5016B3-9F87-4CDE-89CD-E4738E93D77FQ26750234-E7493C24-2061-4B54-A578-8E100DD91FC9Q26825025-C38A72F6-F0F7-4E5C-BFC6-ADD82E38ADCBQ28077539-593BF678-3753-4546-B7DA-92B639BF5F93Q28536088-C6D96EA9-EAC0-41C2-B602-ED9CF759C75EQ28543851-0A0A2DF0-EE3E-4A24-BC9C-B495F9CD200CQ30566256-1F2C0029-28E5-407E-B469-6F1DCFD0FDAAQ33762602-C7EE9EDC-611F-44CF-9C41-7B7839BB5551Q33891744-DEA6B122-E584-4402-BDA3-167AD9EF1422Q34194593-DE81C1D5-87E6-49D4-B247-662F3594A723Q34612180-13F9313E-9191-450F-86C6-8C4AFF5DBC68Q34927586-9BACC2C4-C177-4600-B858-634BADAE3677Q34978968-02A69D71-5429-4DD4-89C8-16D1278FA962Q35126647-4DE21EE5-6D31-4543-9E82-2F3DDF6265A3Q35325232-B40F40F3-0D1B-45FF-852A-924A032E5BC4Q35937562-14C206D4-F374-4E97-B127-E06F274F699AQ36169626-9D7530D7-91A8-41C7-ABAA-3C472CA986F8Q36869503-973EE7C9-9492-4A88-9939-C6856D128CC6Q36933398-8E4C6CAD-F829-4717-A012-117CCE82C68CQ37272449-4C44AF46-D2DC-479F-89AA-C6383A13FBD3Q37288871-DF681CD6-9BAC-474B-9210-B0CD21213A4FQ37401820-E2D5D0C1-4DAE-41B6-A254-2E2BE92C47DBQ38742510-939A14E4-F69E-4344-B2FC-B37FA9F36212Q38862724-51111895-78BE-4200-8782-BACF4C90552EQ38954338-DDF01CE4-365A-4382-9709-6FB4A572E507Q39129483-0FB23937-64AE-4BE5-BEAC-94C3DE55D4EAQ39168166-935C42BE-B14E-473A-B2DE-380E1AA5EFC2Q40088256-0AF9E5DA-31C7-4A64-86B5-69814CE598A5Q40748178-E81C23A6-1442-4926-B6E1-A6E18052FF1DQ41093214-7CE6F5B2-72CE-44B4-9919-4D39D439642FQ42213772-82513ADD-F35A-4E7A-8343-68509C312C16Q44792383-2422E36B-AF70-45DB-95D6-0070B649A735Q49755128-0E03CF9C-AA07-4D7F-A906-25AA8692E5ABQ54260673-C4DC7738-5433-488E-AA7E-CB00F9357A8EQ58573679-C4900336-422E-42E2-9C01-60E53EBE37C8
P2860
Chagas disease. What is known and what should be improved: a systemic review.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Chagas disease. What is known and what should be improved: a systemic review.
@ast
Chagas disease. What is known and what should be improved: a systemic review.
@en
Chagas disease. What is known and what should be improved: a systemic review.
@nl
type
label
Chagas disease. What is known and what should be improved: a systemic review.
@ast
Chagas disease. What is known and what should be improved: a systemic review.
@en
Chagas disease. What is known and what should be improved: a systemic review.
@nl
prefLabel
Chagas disease. What is known and what should be improved: a systemic review.
@ast
Chagas disease. What is known and what should be improved: a systemic review.
@en
Chagas disease. What is known and what should be improved: a systemic review.
@nl
P2860
P1476
Chagas disease. What is known and what should be improved: a systemic review.
@en
P2093
José Borges-Pereira
P2860
P304
P356
10.1590/S0037-86822012000300002
P577
2012-06-01T00:00:00Z